Artwork
iconShare
 
Manage episode 524451059 series 3451071
Content provided by Marc Verbenkov. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Marc Verbenkov or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Marc and Henry O’Connell explore how AI-driven vocal biomarkers are transforming mental health, neurological screening, and global access to healthcare.

About the Episode:

This episode explores the extraordinary rise of voice-based diagnostics and the future of AI-driven healthcare. Marc and Henry examine how speech and language biomarkers—once considered speculative—are now validated clinical tools capable of detecting anxiety, depression, cognitive impairment, and early neurodegenerative conditions with remarkable accuracy. The discussion highlights how these non-invasive assessments are being deployed in hospitals, clinics, pharmacies, and even remote regions across the world.

The conversation delves into breakthrough moments, from large-scale mental health assessments in Guatemala to the deployment of multilingual AI models capable of identifying emotional states across languages and dialects. Marc and Henry explore why sub-language vocal signals, controlled by the central nervous system, offer powerful insight into human health—far beyond what traditional word-based methods could achieve.

Looking forward, the episode expands into the role of multimodal data, real-time healthcare monitoring, and AI-powered decision support systems. Together, Marc and Henry imagine a healthcare future where early diagnosis becomes routine, access becomes global, and AI serves as a force multiplier for overburdened medical systems. This vision points toward a world in which advanced diagnostics become as accessible as a smartphone app.

About the Guest:

Henry O’Connell is the CEO and co-founder of Canary Speech, the leading AI-powered health tech company that uses real-time vocal biomarkers to screen for mental health and neurological disorders. Henry has more than twenty years of experience in technology company leadership, both private and public. He has served on the board of directors for several technology companies in the U.S. and internationally. Among his medical diagnostic and technology experience, Henry worked for Hewlett-Packard, Gibson and the National Institutes of Health in neurological research.

Website: https://canaryspeech.com/

Linkedin: https://www.linkedin.com/in/henryjoconnell/

Timestamps:

00:01:09 - Episode Commences
00:02:38 - AI for Mental Health Insights
00:09:48 - Guatemala Mental Health Assessment Program
00:15:11 - Emotion Analysis via Vocal Cues
00:19:08 - Multilingual AI for Mental Health
00:22:38 - Health Monitoring Tools Development
00:29:14 - Vocal Biomarkers for Cognitive Health
00:34:25 - Non-Invasive Vocal Biomarker Test
00:39:02 - AI Healthcare Collaboration: Microsoft and Canary
00:41:54 - AI's Transformative Impact on Healthcare
00:45:42 - Multimodal Diagnostics for Early Detection
00:51:32 - Episode Concludes

Additional Notes:

For more check out the website: https://futuretechandforesight.com/

Or connect with me on –

Twitter: https://twitter.com/FutureTech_Pod

Linkedin: https://www.linkedin.com/company/futuretechandforesight/

  continue reading

210 episodes